Fresenius Medical Care AG (FMS) Research & Development (2016 - 2025)
Historic Research & Development for Fresenius Medical Care AG (FMS) over the last 17 years, with Q3 2025 value amounting to $44.1 million.
- Fresenius Medical Care AG's Research & Development rose 33.9% to $44.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $185.9 million, marking a year-over-year decrease of 1410.08%. This contributed to the annual value of $195.6 million for FY2024, which is 2165.91% down from last year.
- According to the latest figures from Q3 2025, Fresenius Medical Care AG's Research & Development is $44.1 million, which was up 33.9% from $43.1 million recorded in Q2 2025.
- In the past 5 years, Fresenius Medical Care AG's Research & Development registered a high of $77.8 million during Q4 2021, and its lowest value of $43.1 million during Q2 2025.
- Its 5-year average for Research & Development is $57.0 million, with a median of $58.7 million in 2021.
- Its Research & Development has fluctuated over the past 5 years, first surged by 2546.97% in 2021, then crashed by 2475.96% in 2024.
- Fresenius Medical Care AG's Research & Development (Quarter) stood at $77.8 million in 2021, then dropped by 18.68% to $63.3 million in 2022, then grew by 12.26% to $71.0 million in 2023, then decreased by 24.76% to $53.4 million in 2024, then decreased by 17.41% to $44.1 million in 2025.
- Its Research & Development was $44.1 million in Q3 2025, compared to $43.1 million in Q2 2025 and $45.2 million in Q1 2025.